Interestingly, treatment with the IDO-1 enzyme inhibitor BGB-5777, combined with anti-PD1 antibody, as well as radiotherapy in a mouse model of glioblastoma, increased the absolute numbers of CD8 T cells in the tumor and increased survival, when compared to monotherapy with either single agent [80]. This evidence concerns the gene IDO1 and glioblastoma.